18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer

NCT03173924 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

96

Enrollment

NIH

Sponsor class

Conditions

Metastatic Prostate Cancer
Prostatic Neoplasms
Prostate Cancer
Prostatic Cancer
Prostate Neoplasms

Interventions

DRUG: 18F-NaF
DRUG: 18F-DCFPyL
DRUG: 18F-FDG

Sponsor

National Cancer Institute (NCI)